AbstractHIVInternational Workshop on HIV & Women 2020Validating incident pregnancies among women using contraceptives and antiretroviralsView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Determinants of PrEP initiation in women at high risk for HIVView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Not recommended, but done: Breastfeeding with HIV in GermanyView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Women on anti-retroviral therapy (ART) are less likely to achieve HIV RNA <50 copies/ml compared to men – Real World Data from the National Swedish InfCareHIV CohortView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Maternal and cord plasma bioactive eicosanoid profiles differ in pregnant women living with HIV compared to HIV-negative pregnant womenView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Adolescent girls and young women: should they be formally recognized as a key population for HIV?View Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Impact of Dolutegravir based ART among Indian womenView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Vitamin D status in pregnant women living with HIV in Denmark and association with birth outcomes - A nationwide cohort studyView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Outcomes following prenatal exposure to Dolutegravir: the Dolomite-EPPICC StudyView Abstract
AbstractHIVInternational Workshop on HIV & Women 2020Sex-specific analyses in oral abstracts from CROI 2019View Abstract
SlidesetHIVInternational Workshop on HIV & Women 2020Treatment experiences, perceptions towards sexual intimacy and child-bearing, and empowered decision making in care among women living with HIV; Positive PerspectivesView Slideset
SlidesetHIVInternational Workshop on HIV & Women 2020CD4: CD8 Ratio Normalization among Women - Alice Zhabokritsky, MDView Slideset
